A detailed history of J. Goldman & CO LP transactions in Merck & Co., Inc. stock. As of the latest transaction made, J. Goldman & CO LP holds 258,906 shares of MRK stock, worth $25.4 Million. This represents 0.91% of its overall portfolio holdings.

Number of Shares
258,906
Previous 645,636 59.9%
Holding current value
$25.4 Million
Previous $79.9 Million 63.22%
% of portfolio
0.91%
Previous 2.45%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$111.15 - $128.97 $43 Million - $49.9 Million
-386,730 Reduced 59.9%
258,906 $29.4 Million
Q2 2024

Aug 14, 2024

BUY
$123.8 - $132.96 $38.4 Million - $41.2 Million
309,797 Added 92.25%
645,636 $79.9 Million
Q1 2024

May 15, 2024

BUY
$113.24 - $131.95 $18.5 Million - $21.6 Million
163,811 Added 95.22%
335,839 $44.3 Million
Q4 2023

Feb 14, 2024

SELL
$100.18 - $109.02 $13.1 Million - $14.3 Million
-131,167 Reduced 43.26%
172,028 $18.8 Million
Q3 2023

Nov 14, 2023

BUY
$102.95 - $114.33 $31.2 Million - $34.7 Million
303,195 New
303,195 $31.2 Million
Q1 2023

May 15, 2023

BUY
$102.94 - $114.86 $13.9 Million - $15.6 Million
135,428 New
135,428 $14.4 Million
Q3 2022

Nov 14, 2022

BUY
$84.53 - $94.96 $3.03 Million - $3.41 Million
35,877 New
35,877 $3.09 Million
Q4 2021

Feb 14, 2022

SELL
$72.28 - $90.54 $2.61 Million - $3.27 Million
-36,166 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$71.68 - $78.83 $2.59 Million - $2.85 Million
36,166 New
36,166 $2.72 Million
Q2 2021

Aug 16, 2021

SELL
$70.31 - $77.77 $183,649 - $203,135
-2,612 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$68.86 - $81.11 $179,862 - $211,859
2,612 New
2,612 $201,000
Q4 2020

Feb 16, 2021

SELL
$71.77 - $79.65 $5.81 Million - $6.45 Million
-80,937 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$73.18 - $82.95 $5.92 Million - $6.71 Million
80,937 New
80,937 $6.71 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $248B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track J. Goldman & CO LP Portfolio

Follow J. Goldman & CO LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

News

Stay updated on J. Goldman & CO LP with notifications on news.